Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine in Chinese adults: a randomised, double-blind, placebo-controlled, phase 1 trial by Gui-Ling Chen, MD, Xiao-Feng Li, ProfPhD, Xia-Hong Dai, PhD, Nan Li, BD, Meng-Li Cheng, MSc, Zhen Huang, MSc, Jian Shen, MD, Yu-Hua Ge, BD, Zhen-Wei Shen, PhD, Yong-Qiang Deng, PhD, Shu-Yuan Yang, MSc, Hui Zhao, PhD, Na-Na Zhang, MSc, Yi-Fei Zhang, BSc, Ling Wei, MSc, Kai-Qi Wu, MD, Meng-Fei Zhu, ProfPhD, Cong-Gao Peng, MD, Qi Jiang, BD, Shou-Chun Cao, ProfPhD, Yu-Hua Li, ProfPhD, Dan-Hua Zhao, PhD, Xiao-Hong Wu, PhD, Ling Ni, PhD, Hua-Hao Shen, PhD, Chen Dong, ProfPhD, Bo Ying, PhD, Guo-Ping Sheng, PhD, Cheng-Feng Qin, ProfPhD, Hai-Nv Gao, ProfPhD, Lan-Juan Li, ProfPhD

Get full text